Edition:
United States

Edge Therapeutics Inc (EDGE.OQ)

EDGE.OQ on NASDAQ Stock Exchange Global Select Market

13.95USD
16 Feb 2018
Change (% chg)

$0.05 (+0.36%)
Prev Close
$13.90
Open
$13.84
Day's High
$14.12
Day's Low
$13.84
Volume
17,256
Avg. Vol
23,537
52-wk High
$14.40
52-wk Low
$7.44

Chart for

About

Edge Therapeutics, Inc. is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening critical care conditions. The Company's initial product candidates target rare, acute, life-threat... (more)

Overall

Beta: --
Market Cap(Mil.): $430.49
Shares Outstanding(Mil.): 30.86
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.11 17.27
EPS (TTM): -- -- --
ROI: -- -1.15 35.43
ROE: -- -20.84 17.10

BRIEF-Edge Therapeutics Says EG-1962 Phase 3 Study Continues As Planned Following Completion Of Futility Analysis

* EDGE'S EG-1962 PHASE 3 NEWTON 2 STUDY CONTINUES AS PLANNED FOLLOWING COMPLETION OF FUTILITY ANALYSIS

Dec 29 2017

BRIEF-Edge Therapeutics reports qtrly loss per share $‍0.37​

* Edge Therapeutics reports third quarter 2017 financial results

Nov 01 2017

BRIEF-Edge Therapeutics appoints Rosemary Crane to Board of Directors

* Edge Therapeutics appoints Rosemary A Crane, pharmaceutical industry leader, to its Board Of Directors

Sep 19 2017

Earnings vs. Estimates